Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Capital Work in Progress

    Back to Balance Sheet
AD     Remove this Ad

GLENMARK PHARMACEUTICALS Last 5 Year Capital Work in Progress History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Capital Work in Progress ₹542 Cr₹419 Cr₹1,066 Cr₹921 Cr₹1,218 Cr

What is the latest Capital Work in Progress ratio of GLENMARK PHARMACEUTICALS ?

The latest Capital Work in Progress ratio of GLENMARK PHARMACEUTICALS is ₹542 Cr based on Mar2025 Consolidated results.
Year Capital Work in Progress
Mar2025₹542 Cr
Mar2024₹419 Cr
Mar2023₹1,066 Cr
Mar2022₹921 Cr
Mar2021₹1,218 Cr

How is Capital Work in Progress of GLENMARK PHARMACEUTICALS Trending?

Years Capital Work in Progress % Change
Mar2025 ₹542 Cr
29.25
Mar2024 ₹419 Cr
-60.66
Mar2023 ₹1,066 Cr
15.71
Mar2022 ₹921 Cr
-24.36
Mar2021 ₹1,218 Cr -

Compare Capital Work in Progress of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹57,008.6 Cr 1.2% 4% 43.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹411,054.0 Cr 0.9% 6.2% -1.3% Stock Analytics
DIVIS LABORATORIES ₹167,075.0 Cr 2% 4.8% 4.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹142,904.0 Cr 3.6% 6% 36.9% Stock Analytics
CIPLA ₹107,358.0 Cr -0.1% -3% -8.4% Stock Analytics
DR REDDYS LABORATORIES ₹106,813.0 Cr 1% 10.8% 4.7% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

1.2%

4%

43.9%

SENSEX

-1.4%

0.4%

8.3%


You may also like the below Video Courses